Premium
Last month, the Indian government allowed some accredited private labs to test coronavirus samples. The move was seen as a positive development for diagnostics chains such as Dr Lal PathLabs Ltd, Metropolis Healthcare Ltd and Thyrocare Technologies Ltd, and an opportunity for investors. However, the situation doesn’t look all rosy ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
